Vimnerixin (AZD4721) is the potent and orally active antagonist of acidic CXC chemokine receptor 2 (CXCR2). Vimnerixin has the potential for the research of inflammatory disease.
体外研究:
Assessment of Pharmacokinetics (PK) profile of Vimnerixin in rat and dog[1].
体内研究:
Assessment of Pharmacokinetics (PK) profile of Vimnerixin in rat and dog.